Myocardial iron overload assessment by T2*magnetic resonance imaging in adult transfusion dependent patients with acquired anemias

被引:108
作者
Di Tucci, Anna Angela [1 ]
Matta, Gildo [2 ]
Deplano, Simona [1 ]
Gabbas, Attilio [3 ]
Depau, Cristina [1 ]
Derudas, Daniele [1 ]
Caocci, Giovanni [4 ]
Agus, Annalisa [5 ]
Angelucci, Emanuele [1 ]
机构
[1] Ctr Oncol Riferimento Reg Armando Businco, Ctr Trapianti, Cagliari, Italy
[2] Radiol Osped Brotzu, Cagliari, Italy
[3] Ematol Osped Nuoro, Cagliari, Italy
[4] Osped Binaghi, Ctr Trapianti, Cagliari, Italy
[5] Osped Microcitem, Cagliari, Italy
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷 / 09期
关键词
cardiac iron; myelodysplastic syndromes; magnetic resonance imaging; T2*;
D O I
10.3324/haematol.12759
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Only limited data are available regarding myocardial iron overload in adult patients with transfusion dependent acquired anemias. To address this topic using MRI T2* we studied 27 consecutive chronic transfusion dependent patients with acquired anemias: (22 myelodysplastic syndrome, 5 primary myelofibrosis). Cardiac MRI T2* values obtained ranged from 5.6 to 58.7 (median value 39.8) milliseconds. Of the 24 analyzable patients, cardiac T2* correlated with transfusion burden (p=0.0002). No patient who had received less than 290 mL/kg of packed red blood cells (101 units=20 grams of iron) had a pathological cardiac T2* value (< 20 ms). All patients who had received at least 24 PRBC units showed MRI T2* detectable hepatic iron (liver T2* value <= 6.3 ms). Only patients with severe hepatic iron overload (T2* <1.4 ms) showed cardiac T2* value indicative of dangerous myocardial iron deposition. Serum ferritin was not significantly correlated with cardiac T2* (p=0.24). Gradient echo T2* magnetic resonance imaging provides a rapid and reproducible method for detecting myocardial iron overload which developed after a heavy transfusion burden equal to or greater than 290 mL/kg of packed red blood cell units.
引用
收藏
页码:1385 / 1388
页数:4
相关论文
共 20 条
[1]  
Alessandrino EP, 2002, HAEMATOLOGICA, V87, P1286
[2]   Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload [J].
Anderson, LJ ;
Holden, S ;
Davis, B ;
Prescott, E ;
Charrier, CC ;
Bunce, NH ;
Firmin, DN ;
Wonke, B ;
Porter, J ;
Walker, JM ;
Pennell, DJ .
EUROPEAN HEART JOURNAL, 2001, 22 (23) :2171-2179
[3]   Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans [J].
Beutler, E ;
Barton, JC ;
Felitti, VJ ;
Gelbart, T ;
West, C ;
Lee, PL ;
Waalen, J ;
Vulpe, C .
BLOOD CELLS MOLECULES AND DISEASES, 2003, 31 (03) :305-309
[4]   Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major [J].
Borgna-Pignatti, C ;
Cappellini, MD ;
De Stefano, P ;
Del Vecchio, GC ;
Forni, GL ;
Gamberini, MR ;
Ghilardi, R ;
Piga, A ;
Romeo, MA ;
Zhao, HQ ;
Cnaan, A .
BLOOD, 2006, 107 (09) :3733-3737
[5]   IRON IN HEART - ETIOLOGY AND CLINICAL SIGNIFICANCE [J].
BUJA, LM ;
ROBERTS, WC .
AMERICAN JOURNAL OF MEDICINE, 1971, 51 (02) :209-&
[6]   Myocardial iron loading by magnetic resonance imaging T2*in good prognostic myelodysplastic syndrome patients on long-term blood transfusions [J].
Chacko, Joseph ;
Pennell, Dudley J. ;
Tanner, Mark A. ;
Hamblin, Terry J. ;
Wonke, Beatrix ;
Levy, Terry ;
Thomas, Peter W. ;
Killick, Sally B. .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (05) :587-593
[7]   International scoring system for evaluating prognosis in myelodysplastic syndromes [J].
Greenberg, P ;
Cox, C ;
LeBeau, MM ;
Fenaux, P ;
Morel, P ;
Sanz, G ;
Sanz, M ;
Vallespi, T ;
Hamblin, T ;
Oscier, D ;
Ohyashiki, K ;
Toyama, K ;
Aul, C ;
Mufti, G ;
Bennett, J .
BLOOD, 1997, 89 (06) :2079-2088
[8]  
Greenberg Peter L, 2006, J Natl Compr Canc Netw, V4, P91
[9]  
Jelali Mohamed Ali, 2006, Cancer Imaging, V6, P182, DOI 10.1102/1470-7330.2006.0030
[10]   Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool [J].
Jensen, PD ;
Jensen, FT ;
Christensen, T ;
Eiskjaer, H ;
Baandrup, U ;
Nielsen, JL .
BLOOD, 2003, 101 (11) :4632-4639